Page last updated: 2024-09-03
kn 04 and glycogen
kn 04 has been researched along with glycogen in 1 studies
Compound Research Comparison
| Studies (kn 04) | Trials (kn 04) | Recent Studies (post-2010) (kn 04) | Studies (glycogen) | Trials (glycogen) | Recent Studies (post-2010) (glycogen) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 25,566 | 576 | 3,794 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Brozinick, JT; Cartee, G; Cushman, SW; Dean, D; Reynolds, TH | 1 |
Other Studies
1 other study(ies) available for kn 04 and glycogen
| Article | Year |
|---|---|
1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Biological Transport; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Hypoxia; Cell Membrane; Deoxyglucose; Glucose; Glucose Transporter Type 4; Glycogen; In Vitro Techniques; Insulin; Insulin Antagonists; Male; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction | 1999 |